BIOCRYST PHARMACEUTICALS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BIOCRYST PHARMACEUTICALS, INC. payments for repurchase of common stock for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. payments for repurchase of common stock for the quarter ending 2011-09-30 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. payments for repurchase of common stock for the quarter ending 2011-06-30 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. payments for repurchase of common stock for the quarter ending 2011-03-31 was $61.00K.
- BIOCRYST PHARMACEUTICALS, INC. payments for repurchase of common stock for fiscal 2011 was $61.00K, a 1120.00% increase from fiscal 2010.
- BIOCRYST PHARMACEUTICALS, INC. payments for repurchase of common stock for fiscal 2010 was $5.00K, a 96.77% decline from fiscal 2009.
- BIOCRYST PHARMACEUTICALS, INC. payments for repurchase of common stock for fiscal 2009 was $155.00K.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $61.00K 10-K · filed 2014-03-10 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $62.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $62.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-03-31 | $61.00K 10-Q · filed 2012-05-08 | |
| 2010-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $5.00K 10-K · filed 2013-03-11 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | |
| 2009-12-31 | $155.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |